The way in which fledgling cancer cells self-destruct has been discovered by scientists.
The way in which fledgling cancer cells self-destruct has been discovered by scientists. This finding has the potential of impacting on future cancer therapies. The Trinity College Dublin group was led by Smurfit Professor of Medical Genetics, Professor Seamus Martin.
The team has discovered how a process called 'autophagy' - which literally means 'self-eating' - plays an important role in safeguarding against the development of cancer.
The discovery highlights an unexpected role for a killer protein, called Noxa, in triggering the self-eating process that leads cells in the early stages of cancer to literally eat themselves to death.
Normally, the process of autophagy is switched on when cells experience periods of starvation and in this context is beneficial by helping to keep the 'wolf from the door' until food reappears on the menu.
However, the Martin laboratory has discovered that mutations in a gene called Ras, which is involved in approximately 30 percent of human cancers, triggers excessive autophagy leading to auto-destruction of the fledgling tumour cell. Mutant Ras was found to switch cells into the self-eating mode by ramping up
the production of Noxa. The study suggests that autophagy represents an important natural safeguard against cancer development.
Advertisement
This suggests that drugs targeting Bcl-2 might reactivate the natural self-destruction pathway and help to shrink tumours. The fact that mutant Ras triggers self-destruction of cells carrying this gene also helps to explain why the emergence of fully cancerous cells is relatively rare when we consider that the average human makes hundreds of billions of cells over the course of their lifetime.
Advertisement
The study has been published in the internationally renowned journal, Molecular Cell.
Source-ANI